QuestCap
Inc. (“QuestCap”
or the “Company”) (CSE:QSC; FRA:34C1) is
pleased to announce that its wholly owned subsidiary, Collection
Sites, LLC has launched its previously announced program (see press
release dated August 26, 2020) with RESAAS USA Inc. (TSX-V: RSS) to
provide access to a COVID-19 testing initiative for RESAAS’ network
of real estate agents and their clients in the State of
Nevada.
With a captive audience measuring almost 500,000
real estate professionals across the United States, RESAAS and
Collection Sites kicks off their campaign focused on mobilizing
orders for test kits at an average cost of $60USD per kit.
RESAAS will kick off their campaign in Las
Vegas, Nevada (USA), utilizing existing Collection Sites
operations. Greater Las Vegas has over 15,000 licensed real estate
agents, that serve an estimated 3.6 million customers.
The initiative enables RESAAS agents and their
clients to get tested weekly at Collection Sites testing locations
after convenient online purchase. Tests are facilitated by Alcala
Laboratory Services, LLC, a CLIA-licensed laboratory based in San
Diego, CA. Under the terms of the arrangement, RESAAS will
receive a fee for each test sold by Collection Sites through the
RESAAS network of realtors.
The launch will continue in conjunction with the
planned expansion of Collection Sites locations across the United
States.
“We are working in symphony with some of
America’s leading real estate brands to bring safe and convenient
testing to the real estate industry. This is vital for agents to
continue doing business through the pandemic,” says Mr. Tom
Rossiter, CEO of RESAAS.
Timing couldn’t be better. According to
the John Hopkins University of Medicine and their Coronavirus
resource center, there are now over 6,296,629 confirmed cases in
the United States, with over 189,114 deaths to date.
“This pandemic has affected all people, across
all professions and industries. Real estate is not unscathed,” says
Mr. Rossiter. “The core business of real estate transactions must
be restored as there are countless peripheral businesses and
industry impacted by the lack of leadership and direction under the
circumstances - industries such as finance, property inspectors,
home staging, renovation and restoration along with furniture
stores, moving companies and other services associated with the
buying and selling of residential homes,” says Mr. Rossiter.
“We are committed to getting all industries back
to providing value, serving customers and doing so within a safer
realm of conduct and practice,” stated Mr. Doug Sommerville, the
CEO of QuestCap Inc. “The real estate professional marketplace is
the perfect industry for our Collection Sites operations given the
convenience and accessibility it offers service providers, and the
number of interactions the traditional professional will have with
clients,” concludes Mr. Sommerville.
RESAAS is a global technology platform
exclusively for licensed real estate agents, REALTORS®, brokers,
franchises and associations. The RESAAS platform is an online
marketing channel that generates referrals for agents, acquire
leads in real time and promote listings. “We serve almost 500,000
agents worldwide,” says Mr. Rossiter. “RESAAS has a continued
commitment to providing the real estate industry new and innovative
means to be relevant. We are confident this initiative will provide
our customers with renewed levels of confidence to resume the
business of buying and selling real estate,” says Mr. Rossiter.
About QuestCap Inc.QuestCap
Inc. (CSE:QSC; FRA:34C1) is a social-impact investment
company. Through QuestCap’s three
divisions, MedQuest, TechQuest and ClimateQuest,
it seeks, secures and funds recognized sciences, technologies, and
solutions that impact our global community today.
The QuestCap executive team is complemented by a
panel of global advisors that provide expertise across industries
and geographies. This panel includes prominent immunologist Dr.
Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of
experience in orthopedic treatment, foot and ankle care, and sports
medicine.
QuestCap’s primary focus is the sale of COVID-19
IgG/IgM antibody tests authorized by FDA under an EUA for use by
authorized laboratories. This is achieved largely through two
acquisitions: 100% of Nevada-based Collection Sites, LLC and 28% of
Colombian Sanaty IPS. Collection Sites is setting up a series of
QuestCube COVID-19 testing sites across the United States. The
pop-up labs will be managed by Collection Sites and powered by
Alcala Testing and Analysis Services, a CLIA-licensed laboratory
based in San Diego, California. Appointments and payments will be
handled through the online portal
www.testbeforeyougo.com. Sanaty is setting up a
series of full-service medical clinics offering a complete COVID-19
testing solution.
Other recent MedQuest investments
include: $1M into Sunnybrook Hospital’s Research Group
for Emerging and Respiratory Viruses (such amount payable in equal
$250,000 installments), $0.5M into Sinai Health Foundation’s
research in COVID-19 diagnostic testing (such amount payable in
equal $125,000 installments).
For additional information, please contact:
Doug Sommerville, CEO
Doug.Sommerville@questcapinc.com
For investing enquires please contact:Evan Veryard
evan.veryard@questcapinc.com
For media enquires please contact:Veronica
Welchveronica@vewprmedia.com+1-508-643-8000
Cautionary Note Regarding
Forward-looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation. Forward-looking information includes, but is not
limited to, statements with respect to the launch a COVID-19
testing initiative for real state agents; the pursuit by QuestCap
of investment opportunities; and the merits or potential returns of
any such investments. Generally, forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may",
"could", "would", "might" or "will be taken", "occur" or "be
achieved". Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company, as the case may be, to be materially different from
those expressed or implied by such forward-looking information.
Although the Company has attempted to identify important factors
that could cause actual results to differ materially from those
contained in forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such information will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking information. The Company does not undertake to
update any forward-looking information, except in accordance with
applicable securities laws.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY
FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Resaas Services (TSXV:RSS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Resaas Services (TSXV:RSS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024